Your browser doesn't support javascript.
loading
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022).
Lin, Jialing; Pearson, Sallie-Anne; Greenfield, Jerry R; Park, Kyeong Hye; Havard, Alys; Brieger, David; Day, Richard O; Falster, Michael O; de Oliveira Costa, Juliana.
Afiliação
  • Lin J; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. jialing.lin@unsw.edu.au.
  • Pearson SA; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Greenfield JR; Department of Diabetes and Endocrinology, St Vincent's Hospital, Darlinghurst, Australia.
  • Park KH; St Vincent's Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Havard A; Clinical Diabetes, Appetite and Metabolism, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Brieger D; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Day RO; Endocrinology and Metabolism, National Health Insurance Ilsan Hospital, Goyang-shi, Gyeonggi-do, South Korea.
  • Falster MO; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • de Oliveira Costa J; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Eur J Clin Pharmacol ; 79(9): 1239-1248, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37449993
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália